CrushSCI.com
79.7平均天数
64中位天数
17最短天数
207最长天数
4,1292025发文量

Paper Review Records

全部论文审稿周期

21 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接

97 天

Astragaloside IV ameliorates cognitive impairment after traumatic brain injury with involvement of NMDAR-related signaling

作者
Chenglang Jiang; Weiqi Shen; Xin Liu; Yuhang Hui; Boru Hou展开收起
作者单位
1. The Second Hospital & Clinical Medical School, Lanzhou University , Lanzhou , Gansu , China; 2. Key Laboratory of Biomonitoring and Bioremediation for Environmental Pollution, School of Life Sciences, Lanzhou University , Lanzhou , Gansu , China; 3. Academician Workstation of the Second Hospital & Clinical Medical School, Lanzhou University , Lanzhou , Gansu , China展开收起
PDF源文件 DOI 网页
22 天

Disitamab vedotin combined with PD-1 inhibitors for postoperative adjuvant therapy in upper tract urothelial carcinoma: a retrospective exploratory case series

作者
Yongbao Wei; Huaishan Hong; Dewen Zhong; Ruochen Zhang; Zhixuan Guo; Huang Lin; Jun Lin; Tao Li; Jinfeng Wu; Jianhui Chen; Yi Zhang展开收起
作者单位
1. Department of Urology, Shengli Clinical Medical College of Fujian Medical University, Fuzhou University Affiliated Provincial Hospital, China; 2. Department of Urology, Longyan First Affiliated Hospital of Fujian Medical University, China; 3. Department of Urology, Fujian Medical University Union Hospital, China; 4. Department of Urology, The Affiliated People’s Hospital of Fujian University of Traditional Chinese Medicine, China展开收起
PDF源文件 DOI 网页
26 天

Rare disease clinical trials in Italy (2022–May 2026): current trends, future challenges, and the evolving role as reporting member state

作者
Eleonora De Paola; Fabrizio Galliccia; Raffaella Maione; Natalia Maria Verrelli; Diego Alejandro Dri展开收起
作者单位
1. Clinical Trials Office, Italian Medicines Agency (AIFA), Italy; 2. Department of Pharmacy, School of Specialisation in Hospital Pharmacy, University of Pisa, Italy展开收起
PDF源文件 DOI 网页
48 天

Hormophysa cuneiformis protects against methamphetamine-induced hepatotoxicity via antioxidant, anti-inflammatory, and autophagy-regulatory mechanisms: histological and biochemical studies

作者
Mayada Elhusseiny; Rabab S. El-Kelany; Rania A. El-Shenody; Mohamed S. El-Hashash; Mostafa E. Elshobary; Samar Sami Alkafaas展开收起
作者单位
1. Histology and Cell Biology Department, Faculty of Medicine, Tanta University, Egypt; 2. Forensic Medicine and Clinical Toxicology at the Department of Forensic Medicine and Clinical Toxicology, Faculty of Medicine, Tanta University, Egypt; 3. Botany and Microbiology Department, Faculty of Science, Tanta University, Egypt; 4. Aquaculture Research, AWI-Helmholtz Centre for Polar and Marine Research, Germany; 5. Molecular Cell Biology Unit, Division of Biochemistry, Department of Chemistry, Faculty of Science, Tanta University, Egypt展开收起
PDF源文件 DOI 网页
50 天

Anti-tumor activity of valproic acid in EBV-positive Burkitt lymphoma via PFN2-associated PI3K/AKT pathway repression

作者
Yongliang Zheng; Yuxiu Yang; Shouhua Zhang; Rui Liu; Zujie Lin; Yuanqiao He; Yaoling Luo; Aili He展开收起
作者单位
1. Department of Hematology, The Second Affiliated Hospital of Xi’an Jiaotong University, China; 2. Department of Hematology, The Affiliated Hospital of Jinggangshan University, China; 3. School of Pharmacy, Jiangxi Science and Technology Normal University, China; 4. Department of General Surgery, Jiangxi Provincial Children’s Hospital, The Affiliated Children’s Hospital of Nanchang Medical College, China; 5. Center of Laboratory Animal Science, Nanchang University, China; 6. Key Laboratory of New Drug Evaluation and Transformation of Jiangxi Province, China; 7. Clinical Medicine Research Center, First Affiliated Hospital of Gannan Medical University, China; 8. National-Local Joint Engineering Research Center of Biodiagnostics & Biotherapy, The Second Affiliated Hospital of Xi’an Jiaotong University, China; 9. Department of Tumor and Immunology, Precision Medical Institute, Xi’an Jiaotong University, China; 10. Xi’an Key Laboratory of Hematological Diseases, China展开收起
PDF源文件 DOI 网页
58 天

Male sexual dysfunction associated with TNF-α inhibitors: an indication-stratified global pharmacovigilance analysis

作者
Yi Chu; Min Luo; Wenyu Li; Xuehong Wang; Yuqian Zhou展开收起
作者单位
1. Department of Gastroenterology, The Second Xiangya Hospital of Central South University, China展开收起
PDF源文件 DOI 网页

FAQ

Frontiers in Pharmacology审稿要多久?

截至2026-11-19,CrushSCI 收录了 Frontiers in Pharmacology 的 21 篇完整审稿记录。最快一篇从收稿到录用用了 17 天(Bioresponsive gelatin-coated silk fibroin nanoparticles enhance roxadustat therapy in experimental pulmonary fibrosis,2026-06-28 收稿,2026-07-15 录用),最慢一篇用了 207 天;平均 79.7 天,中位数 64 天。

Expert Matching · Case Demo

把投稿要求,转成可验证的期刊方案

说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。

我们会在半小时内回复。

CrushSCI 在线

客户询问

我是环境工程专业,需要一篇 SCI,希望 3 个月内见刊。没有基金,也没有大牛挂名,可以投哪些期刊?

CrushSCI回复

可以。先按 90 天时限做可行性筛选,同步查找无基金、无知名作者挂靠的典型论文案例,作为选刊依据。重点核对研究质量与期刊 scope。

拟题建议
《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》

样本口径2026 年最近 5 篇有效论文样本

平均审稿59.6 天

中位数65 天

Contact CrushSCI

联系 CrushSCI

留下手机号或微信号,我们将与你确认学术润色、结构优化或一对一辅导咨询需求。

我们会在半小时内回复。

当前选择:学术咨询服务

预留联系方式

也可以直接发送邮件至 leader@crushsci.com

手机号和微信号至少填写一项,仅用于本次咨询联系,不会公开。